Douglass Winthrop Advisors LLC Sells 211 Shares of Mettler-Toledo International, Inc. $MTD

Key Points

• Douglass Winthrop Advisors LLC reduced its position in Mettler-Toledo International by 16.6%, selling 211 shares and now holding a total of 1,060 shares valued at approximately $1,252,000.
• Mettler-Toledo International reported earnings of $10.09 per share, exceeding expectations and showcasing a year-over-year revenue growth of 3.9% to $983.22 million.
• Several analysts have revised their price targets for Mettler-Toledo, with Citigroup increasing its target from $1,400 to $1,600 and Robert W. Baird adjusting theirs from $1,210 to $1,230, while the consensus target price stands at $1,311.11.

Douglass Winthrop Advisors LLC cut its position in Mettler-Toledo International, Inc. (NYSE:MTD - Free Report) by 16.6% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,060 shares of the medical instruments supplier's stock after selling 211 shares during the quarter. Douglass Winthrop Advisors LLC's holdings in Mettler-Toledo International were worth $1,252,000 at the end of the most recent reporting period.

Other large investors have also recently added to or reduced their stakes in the company. Zions Bancorporation National Association UT acquired a new stake in Mettler-Toledo International during the first quarter worth about $43,000. Golden State Wealth Management LLC lifted its holdings in shares of Mettler-Toledo International by 583.3% during the 1st quarter. Golden State Wealth Management LLC now owns 41 shares of the medical instruments supplier's stock worth $48,000 after acquiring an additional 35 shares during the period. Menard Financial Group LLC acquired a new stake in shares of Mettler-Toledo International during the 4th quarter worth approximately $67,000. Blue Trust Inc. increased its stake in Mettler-Toledo International by 520.0% in the first quarter. Blue Trust Inc. now owns 62 shares of the medical instruments supplier's stock valued at $73,000 after acquiring an additional 52 shares during the last quarter. Finally, Quarry LP raised its position in Mettler-Toledo International by 20.5% during the fourth quarter. Quarry LP now owns 88 shares of the medical instruments supplier's stock valued at $108,000 after purchasing an additional 15 shares in the last quarter. Institutional investors own 95.07% of the company's stock.

Mettler-Toledo International Stock Up 3.3%

NYSE MTD opened at $1,320.4310 on Friday. The company has a market capitalization of $27.20 billion, a price-to-earnings ratio of 33.44, a PEG ratio of 3.84 and a beta of 1.34. Mettler-Toledo International, Inc. has a twelve month low of $946.69 and a twelve month high of $1,521.01. The stock has a fifty day simple moving average of $1,227.64 and a 200 day simple moving average of $1,189.10.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last issued its quarterly earnings results on Thursday, July 31st. The medical instruments supplier reported $10.09 earnings per share for the quarter, beating the consensus estimate of $9.58 by $0.51. Mettler-Toledo International had a negative return on equity of 476.07% and a net margin of 21.46%.The company had revenue of $983.22 million during the quarter, compared to analysts' expectations of $957.41 million. During the same quarter in the prior year, the firm posted $9.65 earnings per share. The business's quarterly revenue was up 3.9% on a year-over-year basis. Mettler-Toledo International has set its FY 2025 guidance at 42.100-42.600 EPS. Q3 2025 guidance at 10.550-10.750 EPS. Research analysts expect that Mettler-Toledo International, Inc. will post 42.71 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of research firms have issued reports on MTD. Wall Street Zen cut Mettler-Toledo International from a "buy" rating to a "hold" rating in a research report on Monday, May 5th. Robert W. Baird boosted their target price on shares of Mettler-Toledo International from $1,210.00 to $1,230.00 and gave the stock a "neutral" rating in a research note on Monday, August 4th. Citigroup increased their price target on Mettler-Toledo International from $1,400.00 to $1,600.00 and gave the company a "buy" rating in a research note on Thursday. Bank of America boosted their price objective on Mettler-Toledo International from $1,200.00 to $1,260.00 and gave the stock a "neutral" rating in a research report on Thursday, June 26th. Finally, Wells Fargo & Company upped their target price on Mettler-Toledo International from $1,125.00 to $1,200.00 and gave the stock an "equal weight" rating in a report on Monday, May 5th. Five investment analysts have rated the stock with a Buy rating and five have given a Hold rating to the company's stock. According to MarketBeat, Mettler-Toledo International currently has an average rating of "Moderate Buy" and a consensus target price of $1,311.11.

Insider Activity

In other news, Director Thomas P. Salice sold 1,062 shares of the stock in a transaction on Wednesday, August 13th. The shares were sold at an average price of $1,300.90, for a total transaction of $1,381,555.80. Following the completion of the sale, the director directly owned 283 shares in the company, valued at $368,154.70. This represents a 78.96% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Michael A. Kelly sold 1,062 shares of the company's stock in a transaction dated Wednesday, May 28th. The shares were sold at an average price of $1,159.93, for a total value of $1,231,845.66. Following the sale, the director owned 120 shares in the company, valued at approximately $139,191.60. The trade was a 89.85% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 2,889 shares of company stock valued at $3,603,054. Company insiders own 1.94% of the company's stock.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.